by Jazzmin Huber | Apr 6, 2023 | Research
Researchers at the University of East Anglia have developed a new drug that works against bone cancer including osteosarcoma (OS). The drug, called CADD522, has shown promising results in the laboratory. It will now undergo formal toxicology assessment before...
by Jazzmin Huber | Mar 24, 2023 | Clinical Trials, Research
A clinical trial in the USA is recruiting patients with osteosarcoma and other cancers to test a new drug complex called GD2 SADA: 177 Lu DOTA. This drug uses a new technology where it can disassemble and reassemble itself. By changing the way it’s constructed it can...
by Jazzmin Huber | Mar 9, 2023 | Uncategorized
A clinical trial has opened in Poland that will test whether regorafenib can be used to treat bone cancers. Regorafenib is a type of drug called a tyrosine kinase inhibitor (TKI). TKIs work by blocking the activation of enzymes known as tyrosine kinases. They are...
by Jazzmin Huber | Feb 23, 2023 | Research
In recent years there has been an increase in cancer treatments that target the immune system. So far, these therapies have not been effective in treating osteosarcoma (OS). Researchers are now trying to understand why these treatments are not working. A recent study...
by Jazzmin Huber | Feb 9, 2023 | Clinical Trials, Research
Dr. Matteo Trucco, from Cleveland Clinic Children’s, has launched a sarcoma clinical trial. This clinical trial, based in the USA, aims to see if a drug called disulfiram could be repurposed to be used in sarcoma treatment. Sarcomas are a group of cancers which...
